NorthWest Biotherapeutics Inc (NWBO)

[Investor082]

Eden is not necessary for any regulatory or reimbursement approval. Not submitting reimbursement evidence in UK or a regulatory application in EU (where they could use Advent as a base for manufacturing) is a sign that this management is pathetic and unable to control whats in their hand. And they expect market to value them fairly. Not if you take 4 years to submit one application. But play the victim card!